Back to top

DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo

DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Abbott Laboratories (ABT)

DexCom, Inc. (DXCM)

Medtronic PLC (MDT)

Insulet Corporation (PODD)

Tandem Diabetes Care, Inc. (TNDM)